Response to Harrison et al. ‘Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'

por Gisslinger, H, Jeryczynski, G, Wölfler, A, Beham-Schmid, C, Thiele, J
Publicado 2017

First presentation of a frameshift mutation in the SETD2 gene of a juvenile psammomatoid ossifying fibroma (JPOF) associated with an aneurysmal bone cyst

por Toferer, A., Truschnegg, A., Kashofer, K., Beham-Schmid, C., Beham, A.
Publicado 2021

The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma

por Troppan, K, Deutsch, A, Gerger, A, Stojakovic, T, Beham-Schmid, C, Wenzl, K, Neumeister, P, Pichler, M
Publicado 2014

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

por Troppan, K T, Schlick, K, Deutsch, A, Melchardt, T, Egle, A, Stojakovic, T, Beham-Schmid, C, Weiss, L, Neureiter, D, Wenzl, K, Greil, R, Neumeister, P, Pichler, M
Publicado 2014

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

por Gisslinger, H, Jeryczynski, G, Gisslinger, B, Wölfler, A, Burgstaller, S, Buxhofer-Ausch, V, Schalling, M, Krauth, M-T, Schiefer, A-I, Kornauth, C, Simonitsch-Klupp, I, Beham-Schmid, C, Müllauer, L, Thiele, J
Publicado 2016

Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

por Gisslinger, H, Jeryczynski, G, Gisslinger, B, Wölfler, A, Burgstaller, S, Buxhofer-Ausch, V, Schalling, M, Krauth, M-T, Schiefer, A-I, Kornauth, C, Simonitsch-Klupp, I, Beham-Schmid, C, Müllauer, L, Thiele, J
Publicado 2017